Search for: "Wyeth Pharmaceuticals" Results 301 - 320 of 976
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Dec 2011, 12:25 pm by Greg Blankinship
 While there may be some reasonable market forces at play, American consumers have the right to expect that pharmaceutical companies are not manipulating the market for life-changing drugs just so they can enhance their bottom line. [read post]
13 Dec 2011, 7:49 am by Bexis
Wyeth Pharmaceuticals, Inc., (order here) to decide the following issue:Whether the Superior Court erred in reversing the trial court’s grant of JNOV for [defendant] on [Respondents’] punitive damages claim under Pennsylvania law, where (a) the FDA extensively reviewed and approved the prescription drug at issue, the sufficiency of the testing for that drug, and the drug’s label warnings of the risk of breast cancer, (b) there was no evidence that [defendant]… [read post]
10 Dec 2011, 5:50 am by Barry Eagar
CaseSigma Pharmaceuticals (Australia) Pty Ltd v Wyeth [2011] FCAFC 132Lesson:Applicants should always ensure that the specification currently on file tracks developments. [read post]
28 Nov 2011, 4:02 am by Max Kennerly, Esq.
Big pharmaceutical companies have wiped out most of the potential claims against them except for the “failure to warn,” and that’s a particularly tricky claim. [read post]
25 Nov 2011, 5:00 am by Bexis
 The court finds those claims unpreempted in light of Wyeth v. [read post]
19 Nov 2011, 3:50 am by Gregory Dell
The Plaintiff worked as a Senior Attorney in the Wyeth Pharmaceutical (now Pfizer) Global Business Development Legal Group. [read post]
11 Nov 2011, 5:18 am by Dr Mark Summerfield
Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth [2011] FCAFC 132 (28 October 2011) Appeal from: Sigma Pharmaceuticals (Australia) Pty Ltd v Wyeth Australia Pty Ltd [2010] FCA 1211 See also: Australian Federal Court Blocks Generic EFFEXOR-XR Validity – ‘external’ fair basis – whether claims entitled to priority date of original US application – whether claims are novel Generic pharmaceutical manufacturers Sigma… [read post]
4 Nov 2011, 7:35 am by Walter Olson
[Michelle Yeary, Drug and Device Law] Tags: pharmaceuticals Related posts Wyeth v. [read post]
4 Nov 2011, 6:46 am
Jeanette Rick and other women sued the pharmaceutical company Wyeth, alleging that they developed breast cancer after taking its hormone-replacement drugs. [read post]
2 Nov 2011, 2:00 am by Marie Louise
  Highlights this week included: WIPO Re:Search bridges public, private sectors for neglected disease research (IP Watch) (WIPO) (IPKat) (IP Watch) (Patent Docs) Section 3(d) equivalent in the offing for Thailand…(Spicy IP) Australia: FCAFC upholds claim by Alphapharm that claims 1 to 17 and 27 of Wyeth’s Venlafaxine patent are invalid (IP Whiteboard)   Please join the discussion by adding your comments on any of these stories, and please do let us know if you think… [read post]
31 Oct 2011, 6:46 am by Steve McConnell
Wyeth, 4 A.3d 160, 165 (Pa Super Ct 2010). [read post]
31 Oct 2011, 5:14 am by Walter Olson
[Federalist Society] “I dreamed I swayed the jury… in my Maidenform bra” [Retronaut, scroll] Tags: Arizona, BlackBerry, hate speech, pharmaceuticals, September 11 Related posts October 17 roundup (7) Wyeth v. [read post]
31 Oct 2011, 4:58 am by Max Kennerly, Esq.
When a plaintiff’s lawyer is considering filing dozens or hundreds of lawsuits against GlaxoSmithKline, or AstraZeneca, or Teva Pharmaceuticals, or Siemens Medical, or McNeil Laboratories, or Merck, or Wyeth — all of which have a significant presence in or around Philadelphia — the obvious choice is to file in the quicker venue with more experience and more resources to handle the cases. [read post]
12 Oct 2011, 6:38 am
Louis, I have followed the trials and tribulations of local pharmaceutical company KV Pharmaceutical. [read post]